Exploring the Challenges and Excitement of Whole Genome Sequencing for Embryos

The chapter delves into the complexities and potentials of whole genome sequencing for embryos, discussing the vast amount of genetic information available and the need for better understanding. It highlights the evolving use of genetic testing in fertility treatments, focusing on specific patient groups who could benefit from such testing. The discussion also covers the differences between PGTA and whole-genome testing, as well as the complexities of genetic decision-making in family planning and fertility preservation.